The Positive Airway Pressure Devices market is valued at USD 1.68 billion in 2019 and is expected to reach USD 3.19 billion by 2027, with an annual average growth of 8% from 2021 to 2027.
The increase in patient compliance has helped drive the PAP device market. About 80% of diagnosed patients choose PAP therapy. Most insurance providers provide reimbursement only when a patient adheres to compliance standards for a prescribed amount of time during the first 90-day trial period. This helps patients get compensation from insurance providers who have supported the adoption of PAP devices. The global Positive Pressure Devices market report provides a holistic assessment of the market. The report provides a comprehensive analysis of the key segments, trends, drivers, limitations, competitive landscape, and factors playing an important role in the market.
A full report of Positive Airway Pressure Devices Market available at https://www.orionmarketreports.com/positive-airway-pressure-devices-market/53347/
Positive Airway Pressure Devices Market Segmentations
By Product Type
• Automatic Positive Airway Pressure (APAP) Devices
• Continuous Positive Airway Pressure (CPAP) Devices
• Bilevel Positive Airway Pressure (BiPAP) Devices
By End User
• Sleep Laboratories & Hospitals
• Home Care/Individuals
Company Profiles
• A.L.M.T. Corp.
• CBMM (COMPANHIA BRASILEIRA DE METALURGIA E MINERAÇÃO)
• China Molybdenum Co., Ltd.
• Global Advanced Metals Pty Ltd
• Global Tungsten & Powders Corp.
• H.C. Starck GmbH
• Ningxia Orient Tantalum Industry Co. Ltd (OTIC)
• Plansee SE
• Rhenium Alloys, Inc.
• Tejing Tungsten, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
